Endometrial cancer classification: Difference between revisions
Jump to navigation
Jump to search
Line 8: | Line 8: | ||
==Classification== | ==Classification== | ||
Endometrial cancer may be classified according to histology into 2 types: | Endometrial cancer may be classified according to histology into 2 types: | ||
{| class="wikitable" | {| class="wikitable" | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Type | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Type | ||
Line 22: | Line 18: | ||
| style="background:#F5F5F5;" align="center" + |Endometroid (adenocarcinoma) | | style="background:#F5F5F5;" align="center" + |Endometroid (adenocarcinoma) | ||
| style="background:#F5F5F5;" align="center" + |Favorable (estrogen-responsive) | | style="background:#F5F5F5;" align="center" + |Favorable (estrogen-responsive) | ||
| style="background:#F5F5F5;" align="left" + |• May arise from atypical hyperplasia < | | style="background:#F5F5F5;" align="left" + |• May arise from atypical hyperplasia <br> • Linked to unopposed estrogen stimulation | ||
| style="background:#F5F5F5;" align="center" + |80% | | style="background:#F5F5F5;" align="center" + |80% | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |Type II | | style="background:#DCDCDC;" align="center" + |Type II | ||
| style="background:#F5F5F5;" align="left" + |• Endometroid < | | style="background:#F5F5F5;" align="left" + |• Endometroid <br>• Serous <br>• Clear cell <br>• Mucinous <br>• Squamous <br>• Mesonephric <br>• Undifferentiated | ||
| style="background:#F5F5F5;" align="center" + |Typically bad prognosis | | style="background:#F5F5F5;" align="center" + |Typically bad prognosis | ||
| style="background:#F5F5F5;" align="left" + |• Develops from atrophic endometrium < | | style="background:#F5F5F5;" align="left" + |• Develops from atrophic endometrium <br>• Not linked to hormonally driven pathogenesis | ||
| style="background:#F5F5F5;" align="center" + |15-20% | | style="background:#F5F5F5;" align="center" + |15-20% | ||
|} | |} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 18:39, 26 November 2018
Endometrial cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial cancer classification On the Web |
American Roentgen Ray Society Images of Endometrial cancer classification |
Risk calculators and risk factors for Endometrial cancer classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
Endometrial cancer may be classified according to histology into either type I comprising 80% of endometrial cancers or type II accounting for around 20%.
Classification
Endometrial cancer may be classified according to histology into 2 types:
Type | Histology | Prognosis | Pathogenesis | Prevalence |
---|---|---|---|---|
Type I | Endometroid (adenocarcinoma) | Favorable (estrogen-responsive) | • May arise from atypical hyperplasia • Linked to unopposed estrogen stimulation |
80% |
Type II | • Endometroid • Serous • Clear cell • Mucinous • Squamous • Mesonephric • Undifferentiated |
Typically bad prognosis | • Develops from atrophic endometrium • Not linked to hormonally driven pathogenesis |
15-20% |